clinical-practice-asthma-ba
Got Allergy?

If you or someone you know qualifies, payment for time and travel is provided.
Click here to apply online

AAMG in the News
About Allergies About Asthma About Rhinitis

IgE (Xolair)

  Xolair

  Xolair is a monoclonal antibody that targets IgE, the allergy antibody protein responsible for allergic sensitization.
  Xolair was approved in the year 2003 for the reduction of  asthma exacerbations in patients with persistent 
  moderate to severe asthma. It has proven to be highly effective in select patients in reducing exacerbations,
  improving the quality of life, as well as improving lung function.

  Our office is highly selective in screening and recommending patients for Xolair. Xolair is given by injection
  either once or twice a month for an indefinite period. Our patients who benefit from Xolair have been able to not
  only have less exacerbations and improved quality of life, but also to reduce their dose of corticosteroid
  medications.

  Screening for Xolair encompasses a positive blood test or skin test to a perennial allergen, such as dust mites,
  cat, dog or cockroach and a serum IgE. It also encompasses a history of persistent asthma according to the
  guidelines of the Expert Panel 3, part of the NHLBI which were released in August 2007.

  All of our physicians are experienced with Xolair, as is our physician assistant, and can discuss at length
  specific requirements for treatment as well as appropriate facts about the Xolair injection and potential reactions
  to it. Please do not hesitate to inquire about Xolair or any other treatments for your allergic condition.
 

Allergy Associates Medical Group and Research Center has been serving the San Diego community since 1986
6386 Alvarado Court, Suite 210, San Diego, California 92120
619.286.6687 voice     -     619.286.6695 fax
 Dedicated to Excellence in Respiratory and Allergy Related Disorders.

Copyright © 2008-2011 Allergy Associates Medical Group, Inc., Allergy Associates Research Center